Parkinson’s Disease Volunteers Needed
The Helen Foundation requests volunteers for a new
Parkinson’s disease study to evaluate mental function improvement during
Microdose Therapy.
Hand tremors disappeared for Max Glime while participating
in a Helen Foundation study for his arthritis.
Max had tried to keep his hands from bouncing by holding one hand with
the other. That didn’t work.
Since Max, 30 people with Parkinson’s disease completed
the Helen Foundation arthritis study modified for Parkinson’s disease. Progression
was arrested, patients walked without a shuffle, arms swung while walking, and
tremors were reduced. Professor Virgil
Stenberg who led the research explains “The
importance of this study is finding a complementary, FDA-compliant treatment
that can be used with leva-dopa for Parkinson’s disease.”
The Helen Foundation encourages physicians to use patient
self-administration of cortisone for chronic disease. This use is similar to insulin use for
diabetes and aspirin for headaches. Staying
within safe use limits, patients are taught to use cortisone tablets on the bad
days and not on the good ones. In this
way, so little is used that no significant side effects occur yet inflammation
control is excellent. This is Microdose
Therapy—a small amount when needed.
The 1950 Nobel Prize in Medicine was awarded to discoverers
of cortisone for solving arthritis the first time. Then ‘moon-face’, bone weakening, thinning of
the skin, bleeding under the skin, weight gain, and cataracts appeared in
patients using cortisone. “These
observations are perfectly correct, but the conclusion that cortisone has side
effects is perfectly incorrect.” states
Dr. Stenberg. “Cortisone is a hormone of
the body and as such can have no side effects.
The observations are due to overdosing through lack of understanding how
to use cortisone.”
“Parkinson’s disease appears due to that same difficult-to-detect
cortisone deficiency that causes arthritis.”
says Stenberg. “When the missing
is replaced, the lame walk again, pain is gone, fatigue disappears, and cortisone
is solved arthritis a second time.”
Robert Van Cott, a software engineer with Parkinson’s
disease, explained that he could only concentrate on a subject for 15 minutes
before restlessness drove him away. After
the Helen Foundation study, he could concentrate for five hours. The Helen Foundation requests volunteers for
a new Parkinson’s disease study to evaluate mental function improvement during
Microdose Therapy. The Helen Foundation
telephone number is 1-480-983-8376.
No comments:
Post a Comment